Za zgodą użytkownika stosujemy ograniczoną analitykę chroniącą prywatność, aby zrozumieć, które ścieżki badawcze działają. Nie używamy trackerów reklamowych ani nagrywania sesji. Ten wybór można zmienić w Preferencjach. Przeczytaj Politykę prywatności.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
BRO — frequently asked questions
Is Brown & Brown, Inc. overvalued?
In our latest published analysis dated 2026-10-08, BRO looks meaningfully undervalued. The price recorded at analysis is 62,0 USD versus our fair value of 82,4 USD; the high endpoint is presented separately as potential value of 110 USD. That implies roughly 32.9% upside to fair value at that date.
Our latest published report, analyzed 2026-10-08, gives BRO a fair value of 82,4 USD and a potential value of 110 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for Brown & Brown, Inc.'s archetype; it is a dated research output, not a live price.
Should I buy BRO now?
Our latest published rating for BRO, analyzed 2026-10-08, is Buy. Brown & Brown, Inc. looks meaningfully undervalued at the analysis-date price of 62,0 USD versus fair value of 82,4 USD; potential value is 110 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for BRO?
The dedicated bear-case section in our report analyzed 2026-10-08 documents Brown & Brown, Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is BRO's rating?
Our latest published rating for BRO, analyzed 2026-10-08, is Buy, with a published moat assessment of 7.5/10 (Narrow). It reflects our fair value of 82,4 USD, the potential value of 110 USD, and the price recorded at analysis (62,0 USD).
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.
§1 Podsumowanie wykonawczeEN
Odpowiedź w 30 sekundBuy
Cena a wartość
Cena
$62.02
Wartość godziwa
$82.40
Wartość potencjalna
$109.99
Stan na
2026-10-08
Dlaczego to może zadziałać
The greatest upside catalyst centers on the accelerated extraction of $30M to $40M in operational synergies from Accession combined with rapid scaling of the 180 new casualty programs in Specialty Distribution.
Co zmieniłoby naszą ocenę
Specialty Distribution organic revenue growth decelerating below 0.0% or effective pre-tax cost of debt expanding above 8.27%.
We reiterate our Buy rating on Brown & Brown Inc. (NYSE: BRO) with a fair value of $82.40 USD, representing 32.86% upside against the share price of $62.02 USD as of 2026-10-08. At 12.59x forward earnings, the market is applying an undue discount to Brown & Brown's asset-light business model, superior 27.4% operating margins, and visible top-line expansion from the transformational Accession acquisition. Despite cyclical softening in commercial property catastrophe pricing and elevated post-acquisition debt of $8.07B, Brown & Brown's strong cash flow conversion of 24% to 27% and defensive middle-market client base provide clear visibility toward sustained mid-to-high single-digit earnings compounding.4,5
Valuation7.5 / 10
Management8.5 / 10
Balance Sheet6 / 10
Profitability5.5 / 10
Revenue Growth9 / 10
Risk Assessment7.5 / 10
Competitive Moat7.5 / 10
Earnings Quality8 / 10
Capital Efficiency5.5 / 10
Investor concern currently centers on two primary headwinds: commercial property catastrophe pricing deflation and post-acquisition balance sheet leverage. Excess capacity in catastrophe reinsurance has driven commercial property rates lower, with management noting that a market turn would require $100B to $150B in industry catastrophe losses. Concurrently, second-half 2026 organic revenue growth is guided to moderate to 1.5% to 2.5% in Retail and 2.0% to 4.0% in Specialty Distribution. Furthermore, the Accession transaction expanded total debt to $8,065,999,872 at a 6.27% pre-tax cost of debt against $8.29B in current liabilities, while diluted share count rose to 334.6M shares. These factors have generated market apprehension regarding near-term earnings deceleration and debt service burden.
However, our fundamental examination reveals substantial counter-cyclical and structural insulation. In the Retail segment ($3,406M FY2025 revenue), persistent employer healthcare cost inflation—with medical expenses up 8% to 10% and pharmacy expenses up over 10% —is driving sticky corporate demand for benefits advisory and coverage optimization. In Specialty Distribution ($2,409M FY2025 revenue), the business operates at a premium ~35% operating margin. The rollout of over 180 new programs, heavily weighted toward casualty lines where pricing remains firm, directly buffers against property rate weakness. Moreover, catastrophe property lines are exempt from profit-sharing contingents, protecting division earnings quality.5,7
The integration of Accession provides a step-change in platform scale, adding $1.7B to $1.8B in annual revenue and supporting consensus revenue expectations of $6,985,067,150 for FY2026 and $7,286,172,630 for FY2027. Management has reaffirmed $30M to $40M in operational synergies for FY2026. Crucially, Brown & Brown's model is highly asset-light, requiring just $68M in capital expenditures in FY2025 on $5,902M revenue. With free cash flow conversion established at 24% to 27%, the company is positioned to generate over $1.35B in annual unlevered free cash flow, providing ample capacity to rapidly de-lever the balance sheet while maintaining dividend growth.1,5,6
Trading at 12.59x forward P/E, Brown & Brown trades at an unwarranted discount to peer AJG at 15.34x, despite delivering structural operating margins of 27.36% that exceed AJG's 19.16%. Our synthesized fair value of $82.40 USD reflects consensus EPS progression from $4.48 in FY2026 to $4.81 in FY2027 discounted at an 8.04% Cost of Equity. With an implied return of 32.86%, we recommend an active Buy posture for long-term equity investors.1,2,3,4
Structural Profitability Leadership Over Scale Peers
Brown & Brown generated $2,828 million in operating income on $5,902 million in revenue in FY2025, establishing a 47.92% operating margin that maintains a 2,800+ basis point advantage over scale peer AJG (19.16%). Its Specialty Distribution business sustains ~35% operating margins, driven by proprietary underwriting programs.3,4,5,6
Step-Change Scale and Synergy Capture via Accession
The Accession acquisition expands top-line volume by $1.7 billion to $1.8 billion annually, lifting FY2026 consensus revenue to $6,985,067,150. Management has reaffirmed $30 million to $40 million in year-one cost synergies, driving consensus EPS from $4.48 in FY2026 to $4.81 in FY2027.1,5
Asset-Light Model Generating 24% to 27% Cash Flow Conversion
Capital expenditures were only $68 million in FY2025, reflecting minimal reinvestment requirements of 8% to 10% of NOPAT. The organization consistently achieves 24% to 27% operational cash flow conversion, yielding over $1.35 billion in annual unlevered free cash flow to accelerate debt paydown on the $8.07 billion debt balance.4,5,6
Rekomendacja domu
Buy rating reaffirmed with a synthesized fair value of $82.40 USD, offering 32.86% upside from the current share price of $62.02 USD. Brown & Brown provides a compelling combination of defensive commercial middle-market client retention, structural margin leadership, and cash-flow-driven balance sheet deleveraging.4
Przegląd spółki
Brown & Brown Inc. (NYSE: BRO) is a diversified insurance agency, wholesale brokerage, and underwriting services organization headquartered in Daytona Beach, Florida. Operating through a decentralized corporate structure with over eight decades of market experience, the company delivers risk management, commercial property and casualty placement, employee benefits consulting, and specialized insurance programs across middle-market corporate and institutional clients.
The business is structured into two core operational segments: Retail and Specialty Distribution. The Retail segment generated $3,406 million in revenue for FY2025 (57.7% of consolidated revenues), providing commercial P&C and employee benefits solutions to commercial, public, and personal lines accounts. The Specialty Distribution segment generated $2,409 million in FY2025 (40.8% of revenues), comprising managing general agencies (MGAs) with delegated carrier underwriting authority and wholesale brokerage placement.
Geographically, Brown & Brown derived $5,059 million (85.7%) of FY2025 revenue from the United States, $599 million (10.1%) from the United Kingdom, and $843 million (14.3%) from Other International markets. In 2026, the company completed the transformational acquisition of Accession, expanding expected annual revenue by $1.7 billion to $1.8 billion and cementing its position as a top-tier North American insurance intermediary.
§2 Scenariusz negatywnyEN
The stress test models the combined occurrence of persistent pricing deflation across commercial catastrophe property lines, producer attrition in middle-market retail brokerage, and elevated debt refinancing costs. In this downside regime, catastrophe property pricing deflation continues unchecked without the $100B to $150B in industry losses cited by CEO Powell Brown as necessary to reset capacity. Concurrently, unreplaced commercial producer departures compress Retail organic revenue growth to 1.0%, failing the lower bound of 1.5% to 2.5% guidance. On the balance sheet, refinancing obligations across $8.29B in current liabilities on total debt of $8,065,999,872 at a 200 bps penalty over the current 6.27% pre-tax cost of debt adds $160M in annual debt service. This compound shock reduces consolidated operating margins below 25%, curtails free cash flow conversion below the 24% to 27% target range, and limits capital allocation flexibility to debt defense.
Specialty Distribution organic revenue growth slows below 2.0% as property catastrophe pricing declines broaden5
Jak ta teza może się załamać
Catastrophe Property Pricing Collapse and E&S Commercial Market Softening
CEO Powell Brown confirmed that commercial property catastrophe rates continue to decline without evidence of stabilization absent $100B to $150B in industry catastrophe losses, while admitted carriers aggressively compete for specialty binding programs. Second-half 2026 Specialty Distribution guidance of 2% to 4% fails if pricing deflation broadens, turning organic growth negative and contracting consolidated operating margins from 27.36% reported in FY2025.4,5,6
FV impact
-1.1%
Operating margin 3 points lower throughout
Sygnały wczesnego ostrzegania do monitorowania
Pięć zdarzeń, które osłabiłyby naszą tezę inwestycyjną.
Unreplaced producer departures and moderating admitted commercial P&C pricing breach the 1.0% threshold, decelerating consolidated revenue growth from base Retail revenue of $3,406M.
Obecnie:1.5% to 2.5% guided for 2H 2026
Alarm, jeśli<= 1.0%
02
§3 Przewaga konkurencyjnaEN
Narrow
Brown & Brown commands a narrow economic moat grounded in client switching costs in Retail commercial brokerage and proprietary delegated underwriting authority within Specialty Distribution. In the Retail segment, which generated $3,406M in FY2025 revenue, middle-market commercial accounts depend heavily on decentralized brokers for regulatory risk placement, claim management, and employee benefits optimization. These relationships exhibit substantial stickiness; switching brokers introduces operational friction, plan restructuring disruption, and potential coverage gaps, particularly amid healthcare inflation where medical costs are rising 8% to 10% and pharmacy expenses over 10%.
In Specialty Distribution, which contributed $2,409M in FY2025 revenue, the company's competitive advantage stems from delegated underwriting authority granted by leading insurance carriers. Managing over 180 dedicated programs, Brown & Brown acts as a specialized managing general agent (MGA) and wholesale distributor. Carriers delegate policy binding and risk selection authority because replicating Brown & Brown's niche risk expertise and nationwide wholesale broker network would entail prohibitive fixed costs. This positioning allows Specialty Distribution to generate premium operating margins running around 35%.
Structural profitability further reinforces the moat. Brown & Brown generated $2,828M in operating income on $5,902M revenue in FY2025, establishing a 47.92% operating margin that exceeds direct national peer AJG at 19.16% and WTW at 17.56%. While elevated debt of $8,065,999,872 from the Accession acquisition increases capital-structure leverage, the underlying brokerage business remains fundamentally asset-light ($68M FY2025 capex), enabling steady ROIC of 7.69% above its 7.14% WACC.
Zysk ekonomiczny
Brown & Brown generates positive economic spread, with its return on invested capital of 7.69% exceeding its computed weighted average cost of capital of 7.14% as of 2026-10-08. This spread is underpinned by an asset-light operating model requiring only $68M in FY2025 capital expenditures on $5,902M in revenue, generating $1,363.2M in normalized owner earnings.2,6
7.5/ 10
Narrow
Sources of advantage
01Client Switching Costs in Middle-Market Commercial Brokerage — Commercial insurance placement and employee benefits consulting involve customized workflows, high client administrative integration, and ongoing advisory demand driven by 8% to 10% medical cost inflation and >10% pharmacy cost inflation, securing sticky corporate client relationships across $3,406M in FY2025 Retail revenue.Moderate
02Proprietary Delegated Underwriting Authority and MGA Program Distribution — Brown & Brown commands binding authority and delegated underwriting agreements across over 180 programs, allowing carrier partners to access specialized risk distribution while generating sustainable ~35% operating margins across $2,409M in FY2025 Specialty Distribution revenue.
Znane zagrożenia dla przewagi
Zagrożenie
Powaga
Oś czasu
Złagodzenie
Excess Reinsurance Capital Influx Softening Catastrophe Property Pricing
medium
12 to 24 months
Bifurcated pricing dynamics where casualty lines rate increases offset property declines, onboarding of 180 new casualty programs, and absence of profit-sharing contingents on CAT property lines.5
The highlighted cell is Fair value when every assumption sits at its base level ($82.40). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $1.4B after modeled reinvestment of $118.1M, with terminal value at 82.0% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
The Base case represents the modal operating path, where performance aligns with management guidance and sell-side consensus estimates. Consolidated revenue reaches $6,985,067,150 in FY2026, reflecting the contribution of $1.7B to $1.8B from Accession and organic growth within guided bands of 1.5% to 2.5% in Retail and 2% to 4% in Specialty Distribution. Operating margins remain structurally superior to peers in FY2026, supported by ~35% Specialty Distribution profitability and reaffirmed synergy realization of $30M to $40M. Asset-light operations ($68M capex in FY2025) produce strong operational cash flows of $1.35B+, facilitating steady deleveraging.1,5,6
Accession annual revenue contribution achieves the upper end of guidance at $1.8B
§7 Drzewo decyzyjne wynikówEN
Powyżej
Upgrade the rating; Expand position allocation toward maximum model weight upon confirmation of organic revenue growth accelerating above guided bands and verified debt reduction.
Wyzwalacz: Consolidated FY2026 revenue and quarterly diluted EPS exceeding consensus, driven by Retail and Specialty Distribution organic growth accelerating above guided ranges.
Consolidated revenue exceeding full-year consensus of $6,985,067,150 and quarterly diluted EPS exceeding $0.94, driven by Retail organic growth above 2.5% and Specialty Distribution above 4.0%, confirms accelerated Accession synergy capture ($30M to $40M) and supports rating expansion.
Zgodnie
Maintain Buy; Maintain position at current allocation weight and monitor segment organic growth trajectories alongside quarterly cash conversion.
Wyzwalacz: Consolidated FY2026 revenue and quarterly diluted EPS meeting consensus, supported by Retail and Specialty Distribution organic growth tracking within guided ranges.
Delivery in line with consensus FY2026 revenue of $6,985,067,150 and EPS of $4.48, supported by guided 2H organic growth of 1.5% to 2.5% in Retail and 2% to 4% in Specialty Distribution, sustains the base underwriting trajectory and regular debt paydown.
Poniżej
Downgrade the rating; Pause incremental position additions, evaluate producer departure trends, and stress-test debt service coverage against credit covenants.
Wyzwalacz: Consolidated FY2026 revenue or quarterly diluted EPS falling below consensus, driven by Retail organic growth deceleration or property rate softness dragging Specialty Distribution organic growth below guided bands.
A revenue print below consensus low of $6,907,897,000 or quarterly diluted EPS below $0.84, caused by Retail organic growth breaching 1.0% or property rate softness dragging Specialty Distribution organic growth negative, would impair FY2026 EPS compounding and slow deleveraging of $8,065,999,872 in total debt.
Jakość wyników
Brown & Brown exhibits high underlying earnings quality driven by strong cash flow conversion and transparent fee-based accounting. In FY2025, operating income reached $2,828M on $5,902M revenue, representing an operating margin of 47.92%. Non-cash stock-based compensation of $93M in FY2025 represents a modest 1.58% of revenue, while capital expenditures of $68M confirm minimal asset intensity. CFO Andy Watts reaffirmed long-term free cash flow conversion between 24% and 27%, clarifying that first-half 2026 cash conversion drag stemmed from one-time acquisition earnout settlements that will not recur. In addition, absence of profit-sharing contingents on catastrophe property programs shields operating earnings from extreme claim .
Dynamika prognoz
Consensus estimate revisions following the Q2 2026 release are stable with negligible downward calibration. FY2026 consensus EPS moved slightly from $4.48 to $4.48 per share (-0.03%), while FY2027 consensus EPS adjusted from $4.83 to $4.81 (-0.25%). FY2026 full-year consensus revenue shifted fractionally from $6,987.67M to $6,985.07M (-0.04%), and FY2027 consensus revenue revised from $7,290.85M to $7,286.17M (-0.06%). These minor fractional trims reflect management's prudent 2H 2026 organic growth guidance of 1.5% to 2.5% in Retail and 2% to 4% in Specialty Distribution, rather than structural earnings degradation.1,5
Brown & Brown operates an asset-light commercial brokerage model requiring minimal capital expenditures. In FY2025, capex was $68M on $5,902M in revenue, representing 1.15% capex-to-revenue. Normalized owner earnings reached $1,363.2M ($4.07 per share), incorporating $57.8M in maintenance capex and $367M in depreciation. CFO Andy Watts reaffirmed that the business runs at a 24% to 27% free cash flow conversion rate over the long term, with FY2026 projected free cash flow to firm reaching $1,358.4M. This strong operational cash generation supports debt servicing on $8,065,999,872 in total debt while funding disciplined reinvestment at 8.0% to 10.0% of NOPAT.
Brown & Brown's return on invested capital remains stable at 7.69%, supported by strong operating profitability across Retail and Specialty Distribution segments and modest fixed capital requirements ($68M capex in FY2025). While the Accession acquisition enlarged the invested capital base through goodwill and debt, operational synergies ($30M to $40M reaffirmed) and high cash conversion protect the return profile.
ROIC of 7.69% exceeds computed WACC of 7.14% as of 2026-10-08, generating positive economic profit.
Structural Operating Margin Leadership Over National Broker Peers
Most przepływów pieniężnychJak przepływy operacyjne przełożyły się na wolne przepływy pieniężne w FY2025.
StockMarketAgent.AI
Uzgodnienie przepływów operacyjnych
Zysk netto1,1 mld USDAmortyzacja+367 mln USDWynagrodzenie w akcjach+93 mln USDPozostałe korekty operacyjne−64 mln USDOperacyjne przepływy pieniężne1,5 mld USD
Uzgodnienie środków na początek i koniec
Środki pieniężne na początek2,5 mld USDOperacyjne przepływy pieniężne+1,5 mld USDPrzepływy inwestycyjne−7,9 mld USDPrzepływy finansowe+7,7 mld USDWpływ kursów walutowych+64 mln USDŚrodki pieniężne na koniec3,8 mld USD
Brown & Brown Inc. (BRO) trades at 12.6x forward earnings against a peer median of 15.6x. Its EV/EBITDA of 9.6x compares with a peer median of 13.3x. The comparison uses 4 peers: Arthur J. Gallagher & Co., Erie Indemnity Company, Willis Towers Watson Public Limited Company and SoFi Technologies, Inc., as of 2026-10-08.
§10 Branża i cyklEN
Faza cyklu
Contraction
Industry benchmark capex-to-revenue is 0.55 and capex-to-depreciation is 0.24 as of 2026-10-05, while Brown & Brown's internal capex was $68M in FY2025 on $5,902M revenue. Meanwhile, commercial property insurance capacity has expanded significantly, leading to pricing declines in catastrophe lines.5,6
Cykl byczy
A hardening commercial P&C cycle expands brokerage fee and commission revenues as carriers raise premium rates across commercial property, casualty, and executive lines. Concurrently, high inflation in corporate employee benefits—with medical costs rising 8% to 10% and pharmacy costs rising over 10% —drives corporate client demand for advisory solutions, expanding Retail brokerage revenues. In non-admitted markets, complex casualty risk increases allow specialized wholesale brokers to capture favorable terms.
Cykl niedźwiedzi
A softening commercial insurance pricing cycle, marked by excess property catastrophe reinsurance capacity and admitted market rate competition, reduces premium rates and percentage-based brokerage commissions. CEO Powell Brown highlighted that commercial catastrophe property rates continue to decrease without stabilization absent $100B to $150B in industry insured losses. In addition, admitted carriers are actively competing for specialty programs, while commercial admitted rates are moderating slightly.
Trendy długoterminowe
Trend
Wpływ
Uwaga
Commercial Healthcare and Pharmacy Cost Inflation
positive
Employer medical costs rising 8% to 10% and pharmacy costs increasing over 10% create sustained demand for middle-market employee benefits consulting and plan design.
Expansion of Excess & Surplus (E&S) Specialty Placement
positive
Complex corporate risks increasingly shift from admitted markets to non-admitted specialty and wholesale channels, where Brown & Brown operates over 180 delegated authority programs.
Pozycjonowanie
Brown & Brown is well-positioned to navigate the transitioning insurance market through segment and geographic diversification. The company buffers softening catastrophe property pricing by rolling out over 180 casualty-driven specialty programs and capitalizing on steady demand for corporate employee benefits consulting. In addition, geographic expansion in the United Kingdom ($599M FY2025 revenue) and Other International markets ($843M) mitigates domestic US property pricing cycles.5,7
§11 Zarządzanie pozycjąEN
Wielkość pozycji
3-5%
Position sizing of 3% to 5% balances 32.86% implied upside to fair value midpoint ($82.40) and structural operating margin superiority (27.36% vs AJG at 19.16%) against balance-sheet leverage ($8,065,999,872 in total debt) and slowing 2H organic growth guidance.3,4,5
Ryzyko
Portfolio risk management maintains a strict 5.0% allocation cap for Brown & Brown. While the company demonstrates superior cash flow generation and defensive non-discretionary insurance brokerage characteristics, total debt of $8,065,999,872 at a 6.27% pre-tax cost of debt necessitates active monitoring of free cash flow conversion and credit spread trends across $8.29B in current liabilities.
Transze wejścia
Poziom
Działanie
Dlaczego
$60.00 to $62.02
Initiate primary tranche (50% of target allocation)
Share price of $62.02 as of 2026-10-08 trades at an attractive discount to fair value midpoint ($82.40), providing favorable risk/reward.
$56.00 to $58.00
Accumulate secondary tranche (remaining 50% of target allocation)
Transze wyjścia
Poziom
Działanie
$82.40
Trim 30% to 40% of position upon reaching valuation midpoint
$100.00 to $109.99
Harvest remaining position as shares approach valuation ceiling
Brown & Brown trades at an appealing 12.59x forward P/E against peer AJG at 15.34x, while generating an industry-leading 27.36% operating margin and 24% to 27% cash flow conversion. The Accession acquisition adds $1.7B-$1.8B in revenue, offering excellent multi-year earnings compounding visibility toward our $82.40 USD fair value.3,4,5
Defensive Total Return Investors
Buy
The non-discretionary nature of commercial property & casualty insurance placement and sticky middle-market client relationships provide strong earnings defense through economic cycles. Counter-cyclical employee benefit demand driven by 8% to 10% medical cost inflation further insulates earnings, supporting an attractive 32.86% implied return from current levels.4,5,7
Income & Dividend-Focused Investors
Hold
Although Brown & Brown grew dividends per share by 10% in Q2 2026, the current $0.66 annual dividend yields approximately 1.06% on the $62.02 share price. Near-term capital allocation is prioritizing debt reduction across the $8.07B debt stack rather than aggressive dividend hikes, suggesting pure yield-seekers should maintain a Hold posture.4,5
§14 Końcowa rekomendacjaEN
Działanie
Kupuj
We recommend an active Buy on Brown & Brown Inc. at $62.02 USD, targeting a fundamental fair value of $82.40 USD. The stock's compressed forward multiple of 12.59x overlooks the platform expansion delivered by the Accession transaction ($1.7B-$1.8B annual revenue) and sustained 27.4% operating margins.4,5
While commercial property catastrophe rate softening and post-acquisition debt of $8.07B represent genuine monitoring checkpoints, durable cash flow conversion of 24% to 27% provides strong debt-service coverage and compounding visibility toward consensus FY2027 EPS of $4.81.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Retail organic revenue growth decelerates toward 1.0% due to producer attrition5
Debt servicing friction across $8.07B in total debt at 6.27% pre-tax cost limits share buybacks2,4
The Bear scenario reflects prolonged softness in commercial property catastrophe pricing, where excess capacity continues to depress rates absent the $100B to $150B in industry losses required to reverse pricing. Admitted carrier competition expands in non-admitted specialty markets, reducing Specialty Distribution organic growth. Concurrently, unreplaced producer departures in Retail slow middle-market expansion toward 1.0%. Meanwhile, servicing $8,065,999,872 in total debt at a 6.27% pre-tax cost of debt amid $8.29B in current liabilities elevates annual interest expense, restricting capital return and dampening valuation multiples.
Trigger
Within 12 months
Post-Accession Debt Refinancing Shock and Balance Sheet Distress
Brown & Brown holds $8,065,999,872 in total debt as of 2026-10-08 at a 6.27% pre-tax cost of debt against a 5.27% risk-free rate. A 200 bps widening in credit spreads upon refinancing maturing notes across the $8.29B current liabilities stack elevates annual interest obligations by over $160M, compressing free cash flow conversion from management's 24% to 27% target and forcing multiple contraction.2,4,5,6
FV impact
-19.6%
Cost of capital 2 points higher
Trigger
Within 18 months
Retail Producer Defections and Macroeconomic Organic Growth Stagnation
Retail segment organic revenue growth is guided to 1.5% to 2.5% for 2H 2026, while management noted ongoing talent losses with unreplaced producer positions and admitted commercial lines pricing moderation. If commercial producer departures accelerate and organic growth breaches 1.0%, top-line expansion falters below consensus expectations of $6,985,067,150 for FY2026, impairing per-share earnings compounding.1,5
FV impact
-3%
Revenue and EPS growth 5 points lower for five years
Credit spread widening of 200 bps upon refinancing maturing obligations across $8.29B in current liabilities on total debt of $8,065,999,872 elevates annual interest expense by over $160M.
Obecnie:6.27% pre-tax cost of debt as of 2026-10-08
Erosion of delegated underwriting authority commissions or pricing competition contracts segment operating profitability below 30%, pulling consolidated operating margins down from FY2025 level of 27.36%.
Foreign currency fluctuations and integration friction across UK ($599M) and European operations stall international expansion, leaving Brown & Brown fully exposed to moderating domestic US property rates.
Obecnie:24.4% of consolidated revenue ($1,442M) in FY2025
Alarm, jeśli<= 0.0%
Wide
03Wholesale Platform Scale and Carrier Access Advantage — Scale across domestic US brokerage ($5,059M in FY2025) and international wholesale hubs including the UK ($599M) and Other International ($843M) enables privileged placement relationships and reinsurance distribution differentiation.Moderate
Talent Poaching and Commercial Producer Turnover
low
6 to 12 months
Decentralized entrepreneurial operating culture, performance-based equity incentives ($93M SBC in FY2025), and active hiring to backfill and upgrade talent in affected markets.5,6
Admitted Carrier Encroachment into Non-Admitted E&S Business
medium
12 to 18 months
Specialized niche underwriting expertise and rapid expansion into complex casualty programs that admitted carriers lack appetite or authority to bind.5
Discounted forecast-period cash flows (19,51 USD) plus discounted terminal value (88,79 USD) minus signed per current share (19,53 USD) equals the 88,77 USD lens value shown above. Negative net debt is , so subtracting it raises value.
In the Bull scenario, Accession integration exceeds operational targets, delivering the upper bound of $1.8B in annual revenue and achieving $40M in cost synergies. Specialty Distribution maintains operating margins of approximately 35% as the rollout of over 180 casualty-driven programs successfully neutralizes catastrophe property rate declines. In Retail, non-discretionary corporate risk and persistent healthcare inflation (medical up 8-10%, pharmacy up over 10%) drive advisory demand, lifting Retail organic growth to the top of guided ranges. High cash flow conversion of 24% to 27% allows Brown & Brown to rapidly pay down debt from its $8.07B stack, prompting multiple expansion toward peer averages.4,5
Capital allocation prioritizes organic growth and balance sheet deleveraging following the Accession acquisition, which increased total debt to $8,065,999,872 as of 2026-10-08. CEO Powell Brown affirmed that organic growth remains the core focus, followed by share repurchases, technology investments, and selective M&A. Brown & Brown increased its quarterly dividend per share by 10% compared to Q2 2025 and repurchased approximately 9 million shares over nine months, partially offsetting dilution from the Accession transaction that brought total shares to 334,610,357. Accession annual revenue is affirmed at $1.7B to $1.8B with $30M to $40M in operational synergies on track for FY2026.
Brown & Brown generated $2,828M in operating income on $5,902M revenue in FY2025, achieving a 47.92% operating margin compared to peer AJG at 19.16% and WTW at 17.56%.
A 2,800+ bps operating margin advantage over national peers provides an earnings cushion to absorb commercial property pricing moderation while funding technology automation.
Asset-Light Brokerage Architecture Drives High Cash Conversion
Wartość godziwa427,31 USDReport-date price288,61 USD
Data oceny
Przewaga konkurencyjnaNarrow
Karta wyników inwestycyjnych66 / 100
SoFi Technologies, Inc.SOFI
Cena / wartość godziwa
Wartość godziwa10,02 USDReport-date price15,23 USD
Data oceny
Przewaga konkurencyjnaNarrow
Karta wyników inwestycyjnych56 / 100
Marża
BRO
Brown & Brown Inc.
$20.8B
12.6x
3.1x
9.6x
10.0%
—
AJG
Arthur J. Gallagher & Co.
$58.2B
15.3x
3.9x
16.5x
6.7%
19.2%
ERIE
Erie Indemnity Company
$11.6B
15.8x
2.8x
13.3x
24.8%
19.1%
WTW
Willis Towers Watson Public Limited Company
$27.1B
12.8x
2.7x
11.5x
19.8%
17.6%
SOFI
SoFi Technologies, Inc.
$19.8B
18.6x
4.6x
7.1%
17.0%
Catastrophe Property Reinsurance Capital Influx
negative
Abundant reinsurance capacity in commercial property lines exerts downward pricing pressure, requiring an estimated $100B to $150B in industry losses to stabilize.
